COMMUNIQUÉS West-GlobeNewswire

University of St. Augustine for Health Sciences Strengthens Community Ties and Champions Hands-on Learning at the 9th Annual U.S. Open Adaptive Surfing Championships
27/08/2026
The celebrated surfing competition gives USAHS students a chance to demonstrate their skills while bringing together adaptive athletes from around the world OCEANSIDE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- The [...]
Jersey College York Campus Marks First Graduation and a New Generation of Nurses in Pennsylvania
27/08/2026
Inaugural graduating class demonstrates how Jersey College's hospital partnership with WellSpan Health creates a pathway from nursing education to the regional workforce YORK, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- [...]
FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in Cattle
27/08/2026
Silver Spring, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm [...]
Affordable ACA Alternatives: Common Healthcare Sharing Questions Answered for 2026
27/08/2026
Healthcare sharing organizations enroll year-round, with no ACA Open Enrollment window, making them accessible to people who need them at any time WeShare Health has shared more than $50 million in medical expenses for [...]
Stryker to participate in the 2026 Wells Fargo Healthcare Conference
27/08/2026
Portage, Michigan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026 , at the Encore Boston Harbor. Preston Wells, Vice [...]
JATT III Acquisition Corp Announces Closing of $69,000,000 Initial Public Offering
27/08/2026
WESTFIELD, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- JATT III Acquisition Corp (the "Company") announced the closing of its initial public offering of 6,900,000 ordinary shares at an offering price of $10.00 per ordinary [...]
Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
27/08/2026
LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating systemic autoimmune disease LISRAYA is a once-daily pill that directly targets key immune [...]
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
27/08/2026
LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating systemic autoimmune disease LISRAYA is a once-daily pill that directly targets key immune [...]
Ally Medical ER Unleashes the Final Stretch of Its Pet Supply Drive with Over 7,000 Donations and a Dog Named Ally Bear
27/08/2026
Two milestones help fuel the freestanding ER's donation drive supporting Texas animals in need throughout the month of August AUSTIN, Texas, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency Room has surpassed [...]
Correction: Entera to Participate in Upcoming Fall Investor Conferences
27/08/2026
TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, [...]
PRM Cosmetic Surgery Announces New Surgeon Training Initiative Led by Dr. Robert Rey
27/08/2026
Known as “Dr. 90210,” Dr. Rey returns to focus on surgeon education, Ayon technology and support for people living with lipedema Dr. Robert Rey, PRM Cosmetic Surgery. LOS ANGELES, Aug. 27, 2026 (GLOBE NEWSWIRE) -- PRM [...]
Fangzhou Reports Sustained Revenue and Profit Growth as AI-Powered Chronic Care Strategy Gains Momentum
27/08/2026
HONG KONG, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, announced its interim results for the six months [...]
Recovery.com’s Tom Farley to Emcee National Recovery Month Kickoff
27/08/2026
MADISON, Wis., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Tom Farley, Community Outreach Director for Recovery.com, will emcee the 2026 Recovery Month Kickoff Luncheon on Thursday, September 3, at the Rayburn House Office [...]
Foundation for Sarcoidosis Research to Host Mid-Atlantic Regional Sarcoidosis Summit in Philadelphia
27/08/2026
Free educational summit brings together nationally recognized specialists, healthcare professionals, patients, and care partners to improve sarcoidosis care across the region PHILADELPHIA, Aug. 27, 2026 (GLOBE NEWSWIRE [...]
Benefits and Risks of Artificial Intelligence (AI) Scrutinized in the Journal of American Physicians and Surgeons
27/08/2026
TUCSON, Ariz., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) in medicine is portrayed as either a gateway to a golden era or a route to hell. In the fall issue of the Journal of American Physicians and [...]
Eascra Biotech Appoints Chief Scientific Officer to Lead Commercialization Push
27/08/2026
Veteran biotherapeutics and genetic medicines leader joins nanomedicine startup to drive commercialization and pharma partnerships BOSTON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Eascra Biotech , a nanomedicine startup, with [...]
Entera to Participate in Upcoming Fall Investor Conferences
27/08/2026
TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, [...]
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor
27/08/2026
HAIFA, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri”), a biotechnology company, leveraging its proprietary three-dimensional ("3D") cell expansion platform across two [...]
Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027
27/08/2026
– Per-protocol interim statistical power analysis confirms no additional patients are recommended for full enrollment – – Second pivotal Phase 3 trial (COVE-3) has already exceeded 50% of current target enrollment, with [...]

Pages